This Duodenal Ulcer Treatment market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The duodenal ulcer treatment market size has grown strongly in recent years. It will grow from $99.99 billion in 2024 to $107.67 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increased patient preference for non-invasive treatments, growth in gastrointestinal health awareness, increase in the number of cigarette smokers, increase in the number of alcohol or tobacco consumers, and increase in the integration of digital health solutions.
The duodenal ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $142.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing number of diseases, an increasing number of medical infrastructure and healthcare facilities, growing awareness about the availability of treatment options, growing preference for minimally invasive procedures, and increasing efforts to spread awareness by the government. Major trends in the forecast period include technological advancements, integration of probiotics, telemedicine, nutritional therapy, and evidence-based practice integration.
The anticipated growth in the duodenal ulcer treatment market is linked to the rising number of cigarette smokers. Cigarette smokers are individuals who regularly consume cigarettes, which are small rolls of paper filled with tobacco that are smoked by inhaling and exhaling the smoke. The rise in cigarette smoking is influenced by cultural factors, public policies, and socioeconomic conditions. Managing duodenal ulcers in smokers requires a thorough approach, including ulcer-specific treatments, smoking cessation programs, lifestyle changes, and continuous monitoring to promote healing and prevent recurrence. For example, data from the Office for National Statistics in the UK revealed that in 2022, approximately 6.4 million adults over 18 were cigarette smokers, representing 12.9% of the population. Additionally, among the 16 to 24 age group, e-cigarette use rose to 15.5% in 2022, up from 11.1% in 2021. This increase in smoking rates is contributing to the expansion of the duodenal ulcer treatment market.
Key players in the duodenal ulcer treatment market are concentrating on creating advanced products, such as combination kits for treating both duodenal ulcers and H. pylori infections, to improve ulcer healing. A combination kit generally involves a therapy that includes medications designed to heal the ulcer and eliminate the H. pylori bacteria. For example, in April 2023, Akums Drugs and Pharmaceutical Limited, an Indian pharmaceutical company, introduced an innovative combination kit for duodenal ulcers related to H. pylori infection. This kit combines three effective medications - amoxicillin, clarithromycin, and esomeprazole - to combat H. pylori bacteria and decrease gastric acid production, addressing the main causes of duodenal ulcers. The Central Drugs Standard Control Organization (CDSCO) has approved this kit for treating duodenal ulcers and eliminating H. pylori in patients with active or healed peptic ulcers.
In June 2022, Glenmark Pharmaceuticals Ltd., an Indian company specializing in duodenal ulcer treatments, acquired over-the-counter (OTC) drug products from Wockhardt Limited for an undisclosed sum. This acquisition highlights Glenmark’s ongoing efforts to expand in the US OTC market and demonstrates its dedication to providing affordable, high-quality medications. Wockhardt Limited, also based in India, is a pharmaceutical and biotechnology company that offers treatments for duodenal ulcers.
Major companies operating in the duodenal ulcer treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz AG, Sun Pharmaceutical Industries Limited, Eisai Co. Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Limited, Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Pharma Limited, Torrent Pharmaceuticals Limited.
North America was the largest region in the duodenal ulcer treatment market in 2024. The regions covered in the duodenal ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the duodenal ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Duodenal ulcer treatment encompasses the methods used to heal and manage ulcers located in the duodenum, the initial segment of the small intestine. This treatment typically includes a mix of medications aimed at decreasing acid production and fostering healing, lifestyle modifications, and occasionally, treatments to eliminate Helicobacter pylori bacteria, which is a frequent cause of duodenal ulcers.
The primary treatment options for duodenal ulcers are antibiotics, proton pump inhibitors, antacids, potassium-competitive acid blockers, H2-antagonists, ulcer-protective drugs, and surgery. Antacids are specifically used to address bacterial infections such as those caused by Helicobacter pylori, which can contribute to the development of duodenal ulcers. This aids in eradicating the bacterial infection and facilitating proper ulcer healing. These treatments are applicable to both adults and the elderly, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The duodenal ulcer treatment market research report is one of a series of new reports that provides duodenal ulcer treatment market statistics, including duodenal ulcer treatment industry global market size, regional shares, competitors with a duodenal ulcer treatment market share, detailed duodenal ulcer treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the duodenal ulcer treatment industry. This duodenal ulcer treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The duodenal ulcer treatment market consists of revenues earned by entities by providing services such as endoscopic therapies, follow-up care, and lifestyle and dietary changes. The market value includes the value of related goods sold by the service provider or included within the service offering. The duodenal ulcer treatment market also includes sales of endoscopic devices, surgical instruments, H2-receptor antagonists, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The duodenal ulcer treatment market size has grown strongly in recent years. It will grow from $99.99 billion in 2024 to $107.67 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increased patient preference for non-invasive treatments, growth in gastrointestinal health awareness, increase in the number of cigarette smokers, increase in the number of alcohol or tobacco consumers, and increase in the integration of digital health solutions.
The duodenal ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $142.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing number of diseases, an increasing number of medical infrastructure and healthcare facilities, growing awareness about the availability of treatment options, growing preference for minimally invasive procedures, and increasing efforts to spread awareness by the government. Major trends in the forecast period include technological advancements, integration of probiotics, telemedicine, nutritional therapy, and evidence-based practice integration.
The anticipated growth in the duodenal ulcer treatment market is linked to the rising number of cigarette smokers. Cigarette smokers are individuals who regularly consume cigarettes, which are small rolls of paper filled with tobacco that are smoked by inhaling and exhaling the smoke. The rise in cigarette smoking is influenced by cultural factors, public policies, and socioeconomic conditions. Managing duodenal ulcers in smokers requires a thorough approach, including ulcer-specific treatments, smoking cessation programs, lifestyle changes, and continuous monitoring to promote healing and prevent recurrence. For example, data from the Office for National Statistics in the UK revealed that in 2022, approximately 6.4 million adults over 18 were cigarette smokers, representing 12.9% of the population. Additionally, among the 16 to 24 age group, e-cigarette use rose to 15.5% in 2022, up from 11.1% in 2021. This increase in smoking rates is contributing to the expansion of the duodenal ulcer treatment market.
Key players in the duodenal ulcer treatment market are concentrating on creating advanced products, such as combination kits for treating both duodenal ulcers and H. pylori infections, to improve ulcer healing. A combination kit generally involves a therapy that includes medications designed to heal the ulcer and eliminate the H. pylori bacteria. For example, in April 2023, Akums Drugs and Pharmaceutical Limited, an Indian pharmaceutical company, introduced an innovative combination kit for duodenal ulcers related to H. pylori infection. This kit combines three effective medications - amoxicillin, clarithromycin, and esomeprazole - to combat H. pylori bacteria and decrease gastric acid production, addressing the main causes of duodenal ulcers. The Central Drugs Standard Control Organization (CDSCO) has approved this kit for treating duodenal ulcers and eliminating H. pylori in patients with active or healed peptic ulcers.
In June 2022, Glenmark Pharmaceuticals Ltd., an Indian company specializing in duodenal ulcer treatments, acquired over-the-counter (OTC) drug products from Wockhardt Limited for an undisclosed sum. This acquisition highlights Glenmark’s ongoing efforts to expand in the US OTC market and demonstrates its dedication to providing affordable, high-quality medications. Wockhardt Limited, also based in India, is a pharmaceutical and biotechnology company that offers treatments for duodenal ulcers.
Major companies operating in the duodenal ulcer treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz AG, Sun Pharmaceutical Industries Limited, Eisai Co. Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Limited, Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Pharma Limited, Torrent Pharmaceuticals Limited.
North America was the largest region in the duodenal ulcer treatment market in 2024. The regions covered in the duodenal ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the duodenal ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Duodenal ulcer treatment encompasses the methods used to heal and manage ulcers located in the duodenum, the initial segment of the small intestine. This treatment typically includes a mix of medications aimed at decreasing acid production and fostering healing, lifestyle modifications, and occasionally, treatments to eliminate Helicobacter pylori bacteria, which is a frequent cause of duodenal ulcers.
The primary treatment options for duodenal ulcers are antibiotics, proton pump inhibitors, antacids, potassium-competitive acid blockers, H2-antagonists, ulcer-protective drugs, and surgery. Antacids are specifically used to address bacterial infections such as those caused by Helicobacter pylori, which can contribute to the development of duodenal ulcers. This aids in eradicating the bacterial infection and facilitating proper ulcer healing. These treatments are applicable to both adults and the elderly, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The duodenal ulcer treatment market research report is one of a series of new reports that provides duodenal ulcer treatment market statistics, including duodenal ulcer treatment industry global market size, regional shares, competitors with a duodenal ulcer treatment market share, detailed duodenal ulcer treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the duodenal ulcer treatment industry. This duodenal ulcer treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The duodenal ulcer treatment market consists of revenues earned by entities by providing services such as endoscopic therapies, follow-up care, and lifestyle and dietary changes. The market value includes the value of related goods sold by the service provider or included within the service offering. The duodenal ulcer treatment market also includes sales of endoscopic devices, surgical instruments, H2-receptor antagonists, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Duodenal Ulcer Treatment Market Characteristics3. Duodenal Ulcer Treatment Market Trends and Strategies4. Duodenal Ulcer Treatment Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Duodenal Ulcer Treatment Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Duodenal Ulcer Treatment Market34. Recent Developments in the Duodenal Ulcer Treatment Market
5. Global Duodenal Ulcer Treatment Growth Analysis and Strategic Analysis Framework
6. Duodenal Ulcer Treatment Market Segmentation
7. Duodenal Ulcer Treatment Market Regional and Country Analysis
8. Asia-Pacific Duodenal Ulcer Treatment Market
9. China Duodenal Ulcer Treatment Market
10. India Duodenal Ulcer Treatment Market
11. Japan Duodenal Ulcer Treatment Market
12. Australia Duodenal Ulcer Treatment Market
13. Indonesia Duodenal Ulcer Treatment Market
14. South Korea Duodenal Ulcer Treatment Market
15. Western Europe Duodenal Ulcer Treatment Market
16. UK Duodenal Ulcer Treatment Market
17. Germany Duodenal Ulcer Treatment Market
18. France Duodenal Ulcer Treatment Market
19. Italy Duodenal Ulcer Treatment Market
20. Spain Duodenal Ulcer Treatment Market
21. Eastern Europe Duodenal Ulcer Treatment Market
22. Russia Duodenal Ulcer Treatment Market
23. North America Duodenal Ulcer Treatment Market
24. USA Duodenal Ulcer Treatment Market
25. Canada Duodenal Ulcer Treatment Market
26. South America Duodenal Ulcer Treatment Market
27. Brazil Duodenal Ulcer Treatment Market
28. Middle East Duodenal Ulcer Treatment Market
29. Africa Duodenal Ulcer Treatment Market
30. Duodenal Ulcer Treatment Market Competitive Landscape and Company Profiles
31. Duodenal Ulcer Treatment Market Other Major and Innovative Companies
35. Duodenal Ulcer Treatment Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Duodenal Ulcer Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on duodenal ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for duodenal ulcer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The duodenal ulcer treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Antibiotics; Proton Pump Inhibitors; Antacids; Potassium-Competitive Acid Blockers; H2-Antagonist; Ulcer Protective Drugs; Surgery2) By Application: Adult; Elderly
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline; Levofloxacin2) By Proton Pump Inhibitors (PPIs): Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
3) By Antacids: Magnesium Hydroxide; Aluminum Hydroxide; Calcium Carbonate; Sodium Bicarbonate
4) By Potassium-Competitive Acid Blockers (P-CABs): Vonoprazan; Tegoprazan
5) By H2-Antagonists (H2 Blockers): Ranitidine; Famotidine; Cimetidine; Nizatidine
6) By Ulcer Protective Drugs: Sucralfate; Misoprostol; Bismuth Subsalicylate
7) By Surgery: Partial Gastrectomy; Vagotomy; Pyloroplasty; Endoscopic Therapy
Key Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.a; Bristol-Myers Squibb
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Duodenal Ulcer Treatment market report include:- Pfizer Inc.
- Merck & Co. Inc.
- Bayer AG
- Sanofi S.A
- Bristol-Myers Squibb
- AstraZeneca plc
- Abbott Laboratories
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sandoz AG
- Sun Pharmaceutical Industries Limited
- Eisai Co. Ltd.
- Aurobindo Pharma Limited
- Cipla Inc.
- Dr. Reddy's Laboratories Limited
- Intas Pharmaceuticals Limited
- Apotex Inc.
- Lupin Limited
- Glenmark Pharmaceuticals Limited
- Alkem Laboratories Limited
- Jubilant Pharma Limited
- Torrent Pharmaceuticals Limited
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | April 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 107.67 Billion |
Forecasted Market Value ( USD | $ 142.82 Billion |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Global |
No. of Companies Mentioned | 25 |